
Titolo | Dasatinib plus Nutlin-3 shows synergistic antileukemic activity in both p53 wild-type and p53 mutated B chronic lymphocytic leukemias by inhibiting the Akt pathway. |
Publication Type | Journal Article |
Authors | Zauli, G, Voltan, R, Bosco, R, Melloni, E, Marmiroli, S, Rigolin, GMatteo, Cuneo, A, Secchiero, P |
PubMed ID | 21106726 |